(follow the blue link to see all embedded URLs)
President Trump is putting American patients first, but Democrats want to make Americans pay more to give free health care to illegal aliens.
Democrats from Pete Buttigieg to Bernie Sanders have all campaigned on plans to take away private health insurance, whether through government-run “public options” or Medicare-For-All:
Nevada Independent: “The union, which provides health insurance to 130,000 workers and their family members through a special trust fund, strongly opposes the Medicare-for-all plans the two candidates support, which would eliminate the union’s health plan by design.”
While the Democrats’ plans would kick nearly 200 million Americans off their health care and require trillions in new tax hikes, President Trump is fighting to lower health care costs and delivering real results.
For the second year in a row, benchmark premiums for Obamacare plans are falling.
Six states have average benchmark plan premiums decreasing 10% or more.
In Michigan and Pennsylvania, individual plans will decrease 6%.
In Florida, individual plans will decrease 2%.
In Wisconsin, individual plans will decrease 9%.
The Trump Administration has made it easier for small businesses and self-employed workers to join together to form Association Health Plans, increasing options for workers.
The Trump Administration has expanded the availability of short-term, limited-duration plans, which offer consumers more choices that “typically cost less than half.”
The cost of prescription drugs in the United States has declined on a year-over-year basis for eight of the past twelve months. With one exception, the last time drug prices went down over a 12-month period was in 1973.
The Trump Administration recently announced a new “Safe Importation Action Plan” that will allow companies to begin importing drugs from other countries, saving Americans money.
Last year, the Trump Administration released the American Patients First blueprint, “a comprehensive plan to bring down prescription drug prices and out-of-pocket costs.”
Within 100 days of the blueprint’s release, “15 drug companies…reduced list prices, rolled back planned price increases, or committed to price freezes for the rest of 2018.”
President Trump has also taken executive action with historic price transparency requirements to increase competition and lower health costs.